共 50 条
- [31] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studiesRHEUMATOLOGY, 2025,Baraliakos, XenofonDeodhar, Atulvan der Heijde, Desireevan den Bosch, FilipMagrey, MarinaMaksymowych, Walter P.Tomita, TetsuyaXu, HujiMassow, UteVaux, TomPrajapati, ChetanManente, MyriamMarten, AlexanderGensler, Lianne S.
- [32] Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI StudyJOURNAL OF RHEUMATOLOGY, 2015, 42 (05) : 799 - 809Ogata, AtsushiAmano, KoichiDobashi, HiroakiInoo, MasayukiIshii, TomonoriKasama, TsuyoshiKawai, ShinichiKawakami, AtsushiKoike, TatsuyaMiyahara, HisaakiMiyamoto, ToshiakiMunakata, YasuhikoMurasawa, AkiraNishimoto, NorihiroOgawa, NoriyoshiOjima, TomohiroSano, HajimeShi, KenrinShono, EisukeSuematsu, EiichiTakahashi, HirokiTanaka, YoshiyaTsukamoto, HiroshiNomura, Akira
- [33] Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (16) : 1605 - 1615Burke, Martin C.Gold, Michael R.Knight, Bradley P.Barr, Craig S.Theuns, Dominic A. M. J.Boersma, Lucas V. A.Knops, Reinoud E.Weiss, RaulLeon, Angel R.Herre, John M.Husby, MichaelStein, Kenneth M.Lambiase, Pier D.
- [34] Efficacy and safety of lurasidone in children and adolescents with bipolar depression: Results from a 2-year open-label extension studyEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S236 - S236DelBello, M. P.Goldman, R.Tocco, M.Pikalov, A.Deng, L.Loebel, A.
- [35] Efficacy and safety of levetiracetam in pediatric patients with epilepsy: a 2-year follow up.PHARMACOTHERAPY, 2003, 23 (10): : 1350 - 1351Hovinga, CA
- [36] The efficacy and safety of rifaximin-a: a 2-year observational study of overt hepatic encephalopathyJOURNAL OF HEPATOLOGY, 2019, 70 (01) : E668 - E668Oey, RosalieBuck, Lennart E. M.Erler, NicoleVan Buuren, HenkDe Man, Robert
- [37] Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-upINTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 292 : 87 - 90Ponticelli, FrancescoTzanis, GiorgosGallone, GuglielmoBaldetti, LucaMangieri, AntonioColombo, AntonioGiannini, Francesco
- [38] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIXHAEMOPHILIA, 2012, 18 : 23 - 24Rothschild, C.Trossaert, M.Claeyssens, S.Lambert, T.Hassoun, A.Volot, F.Dubanchet, A.
- [39] Efficacy, durability, and safety of faricimab in diabetic macular edema: 2-year results from the phase 3 YOSEMITE and RHINE trialsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)Lim, Jennifer I.Wells, John A.Eichenbaum, David AaronDanzig, Carl J.Asik, KemalHaskova, ZdenkaMohan, ShaunSilverman, DavidTang, YannanLin, Hugh
- [40] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIESACTA DERMATO-VENEREOLOGICA, 2024, 104Thaci, DiamantGottlieb, Alice B.Asahina, AkihikoLebwohl, MarkMcInnes, Iain B.Warren, RichardBoehncke, Wolf-HenningInk, BarbaraBajracharya, RajanCoarse, JasonMerola, Joseph F.